Additional lines of evidence suggested that Grb2-associated binding protein 2 (GAB2) should be a leading candidate, due in part to the elevated expression of GAB2 in AML samples observed at both the mRNA and protein levels in multiple datasets (Figure 1, E–H). This evidence concerns the gene GAB2 and acute myeloid leukemia.